Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NTRA | Common Stock | Award | +2.75K | +7.09% | 41.5K | Jun 30, 2023 | Direct | F1, F2 | ||
holding | NTRA | Common Stock | 1.55M | Jun 30, 2023 | by Sofinnova Venture Partners VIII, L.P. | F3 | |||||
holding | NTRA | Common Stock | 1.55M | Jun 30, 2023 | by Sofinnova Venture Partners IX, L.P. | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NTRA | Stock Option (right to buy) | Award | $0 | +4.26K | $0.00 | 4.26K | Jun 30, 2023 | Common Stock | 4.26K | $48.66 | Direct | F4 |
Id | Content |
---|---|
F1 | Represents the issuance of restricted stock units (RSUs) that shall vest in full on June 9, 2024. The RSUs will become fully vested in the event that the Issuer is subject to a change in control. |
F2 | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
F3 | The Reporting Person is a managing member of each of Sofinnova Management VIII, L.L.C. ("Sofinnova Management VIII") and Sofinnova Management IX, L.L.C. ("Sofinnova Management IX"). Sofinnova Management VIII is the general partner of Sofinnova Venture Partners VIII, L.P ., and Sofinnova Management IX is the general partner of Sofinnova Venture Partners IX, L.P . The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. |
F4 | The option shares shall vest and become exercisable in full on June 9, 2024. The option shares will become fully vested and exercisable in the event that the Issuer is subject to a change in control. |